tiprankstipranks
Trending News
More News >
Perspective Therapeutics (CATX)
:CATX
US Market

Perspective Therapeutics (CATX) Income Statement

Compare
1,606 Followers

Perspective Therapeutics Income Statement

Last quarter (Q4 2025), Perspective Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Perspective Therapeutics's net income was $-37.49M. See Perspective Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Jun 22Jun 21
Total Revenue
$ 0.00$ 0.00$ 1.43M$ 7.10M$ 10.79M
Gross Profit
$ 0.00$ 0.00$ 1.43M$ 1.63M$ 4.62M
Operating Expenses
$ 114.45M$ 92.34M$ 42.38M$ 17.43M$ 12.01M
Depreciation and Amortization
$ 3.25M$ 0.00$ 981.00K$ 344.00K$ 248.00K
EBITDA
$ 9.14M$ 10.46M$ -39.96M$ -14.84M$ -7.39M
Operating Income
$ 9.14M$ 10.46M$ -40.94M$ -15.18M$ -7.39M
Other Income/Expenses
$ -113.05M$ -91.83M$ 835.00K$ 512.00K$ 119.00K
Pretax Income
$ -103.91M$ -81.38M$ -40.11M$ -14.67M$ -7.27M
Net Income
$ -103.12M$ -79.28M$ -46.51M$ -14.67M$ -7.15M
Per Share Metrics
Basic EPS
$ -1.40$ -1.23$ -0.85$ -0.27$ -0.13
Diluted EPS
$ -1.40$ -1.23$ -0.85$ -0.27$ -0.13
Weighted Average Shares Outstanding
73.81M 64.42M 54.91M 54.91M 54.91M
Weighted Average Shares Outstanding (Diluted)
73.81M 64.42M 54.91M 54.91M 54.91M
Currency in USD

Perspective Therapeutics Earnings and Revenue History